GO:0001514 selenocysteine incorporation: Protein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001514 (selenocysteine incorporation) describes the co-translational insertion of selenocysteine (Sec) into a growing peptide in response to a UGA codon that is normally a stop signal.
• Selenocysteine is synthesized from serine while charged on its dedicated tRNA (tRNA-Sec), so it is not a post-translational modification of peptidyl-cysteine.
• Recoding of UGA requires a SECIS element in the mRNA and specialized factors such as SECIS-binding protein 2 (SECISBP2) and the Sec-specific elongation factor EEFSEC.
• The efficiency of selenocysteine incorporation is a major determinant of selenoprotein output and is influenced by selenium status, tRNA maturation and translation factors.
• Defects in selenocysteine incorporation are linked to endocrine, neurological and antioxidant-related disease phenotypes, making the pathway a target for functional genomics.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of selenocysteine incorporation genes in human cells.
Description
Selenocysteine incorporation (GO:0001514) is the biological process by which the amino acid selenocysteine is inserted into a nascent polypeptide chain during translation. Unlike the 20 standard amino acids, selenocysteine is not encoded by a dedicated sense codon; instead, it is specified by a UGA codon that is normally read as a termination signal. This process therefore represents a paradigm of codon redefinition, in which the ribosome must distinguish a UGA that specifies selenocysteine from the many UGA codons that terminate translation. The reaction depends on a specialized tRNA (tRNA-Sec) that is first charged with serine and then converted to selenocysteine, after which the charged tRNA is delivered to the ribosome by a dedicated elongation factor. For researchers, GO:0001514 is important because it defines the molecular route by which selenium is used in proteins and because its efficiency controls the abundance of selenoproteins such as glutathione peroxidases and thioredoxin reductases. Selenoproteins participate in redox homeostasis, thyroid hormone metabolism and other processes, so changes in selenocysteine incorporation can alter cellular responses to oxidative stress and endocrine signals. The pathway is also a model for understanding how mRNA sequence elements and trans-acting factors cooperate to reprogram standard genetic decoding. Because selenocysteine incorporation is essential for the function of multiple selenoproteins, it is studied in fields ranging from nutrition and redox biology to neurobiology and cancer research. Experimental systems that manipulate the pathway, including genetic engineering approaches for site-specific selenocysteine insertion, provide tools to dissect its mechanism and its physiological roles.
selenocysteine incorporation At A Glance
| GO ID | GO:0001514 |
|---|---|
| GO term | selenocysteine incorporation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Co-translational insertion of selenocysteine at UGA codons in selenoproteins |
| Codon involved | UGA, normally a stop codon, redefined as selenocysteine |
| Key RNA element | SECIS element in the 3' untranslated region of selenoprotein mRNAs |
| Amino acid precursor | Serine, converted to selenocysteine on tRNA-Sec |
| Representative factors | SECISBP2, EEFSEC, tRNA-Sec |
What Is GO:0001514?
GO:0001514 (selenocysteine incorporation) is the incorporation of selenocysteine into a peptide using a special tRNA that recognizes the UGA codon as selenocysteine rather than as a termination codon. Selenocysteine is synthesized from serine before its incorporation and is not a post-translational modification of peptidyl-cysteine. In other words, the term covers the co-translational decoding event that places selenocysteine at a UGA position within a selenoprotein open reading frame.
Why Is selenocysteine incorporation Important in Cell Biology?
Selenocysteine incorporation is important because it determines whether selenoprotein mRNAs produce functional enzymes containing selenocysteine, and because failure of this process reduces the activity of antioxidant and endocrine-related selenoproteins. The pathway also illustrates how mRNA cis-elements and specialized translation factors can override a canonical stop codon, providing a general model for translational recoding.
• It enables the synthesis of selenoproteins, including glutathione peroxidases and thioredoxin reductases, which depend on selenocysteine for catalytic activity.
• It provides a natural example of codon redefinition, where UGA is read as selenocysteine instead of termination.
• Its efficiency influences cellular redox balance and the response to oxidative stress.
• It is relevant to endocrine biology because selenoproteins participate in thyroid hormone metabolism.
• It is a determinant of how dietary selenium is translated into protein function.
• It is studied in genetic engineering contexts for site-specific selenocysteine insertion into proteins.
• It connects mRNA decay and translation because selenocysteine incorporation can influence the fate of selenoprotein transcripts.
• It is a target for functional genomics because multiple factors act together to control its rate.
What Happens During selenocysteine incorporation?
Synthesis of selenocysteine on tRNA-Sec
In simple terms: The cell builds selenocysteine while it is attached to a special tRNA, starting from serine.
Selenocysteine is synthesized from serine before its incorporation into protein, and this synthesis occurs on a dedicated tRNA species. The tRNA is first charged with serine, and subsequent enzymatic steps convert the serine moiety into selenocysteine, yielding selenocysteinyl-tRNA-Sec. Because the amino acid is made on the tRNA, selenocysteine is not generated by modifying a cysteine residue already present in a polypeptide.
Recognition of the UGA codon and SECIS element
In simple terms: A special signal in the mRNA tells the ribosome that a UGA codon should mean selenocysteine, not stop.
The UGA codon is normally a termination signal, but in selenoprotein mRNAs it can be redefined as selenocysteine. This redefinition depends on a SECIS element, a structured RNA motif that recruits specialized factors to the ribosome. The presence of the SECIS element allows the translation machinery to distinguish a selenocysteine-specifying UGA from a stop codon.
Delivery of selenocysteinyl-tRNA to the ribosome
In simple terms: A dedicated carrier brings the selenocysteine-bearing tRNA to the ribosome.
A selenocysteine-specific elongation factor delivers selenocysteinyl-tRNA-Sec to the ribosomal A site. This delivery step is required for selenocysteine to be incorporated at the UGA codon instead of terminating translation. The interplay between the elongation factor, the SECIS element and the ribosome determines the efficiency of incorporation.
Peptide bond formation and readthrough of UGA
In simple terms: The ribosome adds selenocysteine to the growing protein and continues translating instead of stopping.
Once selenocysteinyl-tRNA is in the ribosomal A site, the ribosome forms a peptide bond and continues elongation rather than terminating at UGA. This readthrough event is the defining outcome of selenocysteine incorporation. The process is co-translational, meaning selenocysteine is inserted as the protein is being synthesized.
Coupling to mRNA stability and decay
In simple terms: How well selenocysteine incorporation works can affect whether the mRNA survives.
Selenocysteine incorporation is connected to mRNA decay pathways, and the efficiency of recoding can influence the stability of selenoprotein transcripts. This coupling means that defects in incorporation may alter both protein output and mRNA fate. The relationship between translation and decay is an active area of research in selenoprotein biology.
Key Genes Involved in GO:0001514 selenocysteine incorporation
The genes and factors below are central to selenocysteine incorporation, covering tRNA maturation, SECIS recognition, elongation and selenoprotein substrates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SECISBP2 | SECIS-binding protein 2; recruits factors to the SECIS element | Key trans-acting factor for UGA recoding |
| EEFSEC | Selenocysteine-specific elongation factor; delivers selenocysteinyl-tRNA | Required for selenocysteine insertion at UGA |
| SEPSECS | Selenocysteine synthase; converts seryl-tRNA to selenocysteinyl-tRNA | Enzyme for selenocysteine synthesis on tRNA |
| PSTK | Phosphoseryl-tRNA kinase; phosphorylates seryl-tRNA-Sec | Step in tRNA-Sec maturation |
| SARS | Seryl-tRNA synthetase; charges tRNA-Sec with serine | Provides serine for selenocysteine synthesis |
| TRU-TCA1-1 | tRNA-Sec gene; serves as the adaptor for UGA recoding | Central RNA component of the pathway |
| GPX1 | Glutathione peroxidase 1; selenoprotein with selenocysteine | Model selenoprotein for incorporation studies |
| GPX4 | Glutathione peroxidase 4; selenoprotein involved in redox defense | Selenoprotein whose function depends on Sec incorporation |
| TXNRD1 | Thioredoxin reductase 1; selenoprotein enzyme | Selenoprotein substrate of the incorporation pathway |
| TXNRD2 | Thioredoxin reductase 2; mitochondrial selenoprotein | Selenoprotein relevant to redox biology |
| SELENOP | Selenoprotein P; selenium transport selenoprotein | Selenoprotein used to assess incorporation capacity |
| SELENOW | Selenoprotein W; small selenoprotein | Selenoprotein model for recoding studies |
| SELENOF | Selenoprotein F; ER-resident selenoprotein | Selenoprotein linked to ER function |
| SELENOK | Selenoprotein K; ER membrane selenoprotein | Selenoprotein studied in incorporation contexts |
| SELENOS | Selenoprotein S; ER-associated selenoprotein | Selenoprotein relevant to stress responses |
| SELENOT | Selenoprotein T; thioredoxin-like selenoprotein | Selenoprotein used in functional studies |
| SELENOH | Selenoprotein H; nucleolar selenoprotein | Selenoprotein model for recoding research |
How Is selenocysteine incorporation Regulated?
Selenocysteine incorporation is regulated at multiple levels, including selenium availability, the abundance of tRNA-Sec and the activity of factors such as SECISBP2 and EEFSEC. The efficiency of UGA recoding can be influenced by the SECIS element and by the translation environment, and defects in these components reduce selenoprotein output. Because the pathway is coupled to mRNA decay, changes in incorporation efficiency can also affect the stability of selenoprotein transcripts.
selenocysteine incorporation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SECISBP2 | Endocrine and neurological phenotypes linked to defective selenocysteine incorporation | Knockout or point-mutation cell models |
| GPX1 | Oxidative stress and redox-related disease biology | Knockout and overexpression models |
| EEFSEC | Impaired selenoprotein synthesis | Knockout and rescue models |
| SEPSECS | Defects in selenocysteine synthesis on tRNA | Point-mutation and knockout models |
| SELENOP | Selenium transport and selenoprotein supply | Knockout and tagged knock-in models |
Selenocysteine incorporation and endocrine/neurological phenotypes
Disruption of selenocysteine incorporation factors can impair selenoprotein synthesis and has been associated with endocrine and neurological phenotypes in studies of the pathway. Because selenoproteins participate in thyroid hormone metabolism and redox control, reduced incorporation can affect these systems. Research on SECISBP2 and related factors has highlighted the importance of recoding for human physiology.
Oxidative stress and glutathione peroxidase biology
Glutathione peroxidase 1 is a selenoprotein whose function depends on selenocysteine incorporation, and its role in health and disease has been extensively reviewed. Changes in selenocysteine incorporation can therefore influence antioxidant defense and redox signaling. This links GO:0001514 to conditions in which oxidative stress contributes to pathology.
mRNA decay and selenoprotein transcript stability
Selenocysteine incorporation is connected to mRNA decay, and defects in the pathway can alter the fate of selenoprotein transcripts. This connection suggests that disease-associated changes in recoding may affect both protein levels and RNA stability. The interplay between translation and decay is relevant to understanding selenoprotein-related disease mechanisms.
From selenocysteine incorporation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for selenocysteine incorporation? | CRISPR knockout cell line |
| Does a specific amino acid change alter incorporation efficiency? | Point-mutation knock-in cell line |
| Can a tagged factor be tracked in live cells? | Tagged knock-in cell line |
| Does increased factor abundance enhance selenoprotein output? | Overexpression cell model |
| Which transcripts depend on the pathway? | Knockout plus RNA-seq or Ribo-seq |
| Can selenocysteine be inserted site-specifically for engineering? | Genetic engineering and synthetic biology models |
How to Study the selenocysteine incorporation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation at UGA codons | Global analysis of selenocysteine incorporation |
| RNA-seq | Transcript abundance and stability | Selenoprotein mRNA analysis |
| Proteomics | Selenoprotein levels and selenocysteine-containing products | Protein output assessment |
| Reporter assays | Readthrough or recoding efficiency at UGA | Functional testing of SECIS elements |
| Genetic engineering | Site-specific selenocysteine insertion | Protein engineering and mechanism studies |
| tRNA analysis | tRNA-Sec charging and maturation | Pathway step analysis |
| Cell viability assays | Redox-related phenotypes | Linking incorporation to cell health |
Ribosome profiling (Ribo-seq)
Ribo-seq can be used to monitor translation at UGA codons and to assess readthrough associated with selenocysteine incorporation. It provides a genome-wide view of translation efficiency for selenoprotein mRNAs. This approach helps connect incorporation efficiency to transcript-level regulation.
RNA-seq and transcript stability analysis
RNA-seq measures transcript abundance and can reveal changes in selenoprotein mRNA levels when incorporation is perturbed. Because incorporation is coupled to mRNA decay, RNA-seq is useful for detecting stability effects. Combining RNA-seq with translation assays gives a more complete picture of pathway output.
Proteomics and selenoprotein detection
Proteomic methods can assess selenoprotein abundance and the presence of selenocysteine-containing products. These approaches help determine whether changes in incorporation translate into changes in protein output. They are complementary to RNA-level measurements.
Genetic engineering for site-specific incorporation
Genetic engineering strategies have been developed to insert selenocysteine site-specifically into proteins, providing tools to study the pathway and to create modified proteins. These methods can be used in bacterial and other expression systems. They support both mechanistic studies and protein engineering applications.
How CRISPR Can Be Used to Study GO:0001514 selenocysteine incorporation
Knockout
CRISPR knockout of genes such as SECISBP2, EEFSEC or SEPSECS can be used to test whether they are required for selenocysteine incorporation. Knockout cell lines provide a clean background for measuring selenoprotein output and UGA readthrough. These models are foundational for causal studies of the pathway.
Point Mutation
Point-mutation knock-in can be used to alter specific residues in factors involved in selenocysteine incorporation and to test their functional importance. Such models help distinguish domains required for tRNA delivery or SECIS recognition. They are useful when complete loss of the gene is lethal or pleiotropic.
Knock-in
Knock-in of tags or reporters allows tracking of selenocysteine incorporation factors in their native context. Tagged knock-in models can be used for imaging and biochemical purification. They support studies of localization and complex formation.
Overexpression
Overexpression of selenocysteine incorporation factors or selenoprotein reporters can be used to test whether increased factor abundance enhances recoding. These models are helpful for gain-of-function experiments and for engineering applications. They complement loss-of-function studies.
How EDITGENE Supports selenocysteine incorporation Research
Researchers studying selenocysteine incorporation-related genes often need to determine whether a candidate gene is causally involved in the pathway, which requires precise genetic models that can isolate loss-of-function, gain-of-function and allelic effects. EDITGENE provides such models to support mechanistic and translational studies of GO:0001514.
Contact EDITGENE today to design your custom CRISPR model for selenocysteine incorporation research.
Frequently Asked Questions About selenocysteine incorporation
What is selenocysteine incorporation?
Selenocysteine incorporation (GO:0001514) is the process by which selenocysteine is inserted into a peptide using a special tRNA that reads UGA as selenocysteine rather than as a stop codon.
What genes are involved in selenocysteine incorporation?
Key genes include SECISBP2, EEFSEC, SEPSECS, PSTK and the tRNA-Sec gene, together with selenoprotein substrates such as GPX1.
Why is UGA read as selenocysteine instead of stop?
A SECIS element in the mRNA and specialized factors allow the ribosome to redefine UGA as selenocysteine in selenoprotein transcripts.
Is selenocysteine a post-translational modification?
No; selenocysteine is synthesized from serine before incorporation and is not a post-translational modification of peptidyl-cysteine.
What is the role of SECISBP2 in selenocysteine incorporation?
SECISBP2 binds the SECIS element and helps recruit the machinery needed for UGA recoding.
How is selenocysteine incorporation studied?
It is studied using reporter assays, Ribo-seq, RNA-seq, proteomics and genetic engineering approaches.
Can CRISPR be used to study selenocysteine incorporation?
Yes; CRISPR knockout, point-mutation, knock-in and overexpression models can test the function of pathway genes.
What diseases are linked to defective selenocysteine incorporation?
Defects have been associated with endocrine and neurological phenotypes and with altered redox biology.
What is the difference between selenocysteine and cysteine?
Selenocysteine contains selenium in place of sulfur and is incorporated co-translationally at UGA, whereas cysteine is a standard amino acid.
Why is selenocysteine incorporation important for antioxidant defense?
Selenoproteins such as glutathione peroxidase 1 require selenocysteine for catalytic activity and participate in redox defense.
Conclusion
GO:0001514 (selenocysteine incorporation) defines a specialized translation process in which UGA is redefined to insert selenocysteine into selenoproteins. The pathway depends on tRNA-Sec, SECIS elements and factors such as SECISBP2 and EEFSEC, and its efficiency influences redox and endocrine-related biology. CRISPR-based models provide a rigorous way to test the causal roles of these components in human cells.
References
- 1. Wang Y et al.. 2021. Site-Specific Selenocysteine Incorporation into Proteins by Genetic Engineering.. Chembiochem 22(20):2918-2924 PMID: 33949764
- 2. Peng JJ et al.. 2021. Mechanisms Affecting the Biosynthesis and Incorporation Rate of Selenocysteine.. Molecules 26(23) PMID: 34885702
- 3. Stadtman TC. 1996. Selenocysteine.. Annu Rev Biochem 65:83-100 PMID: 8811175
- 4. Handy DE et al.. 2022. The role of glutathione peroxidase-1 in health and disease.. Free Radic Biol Med 188:146-161 PMID: 35691509
- 5. Fu X et al.. 2018. Challenges of site-specific selenocysteine incorporation into proteins by Escherichia coli.. RNA Biol 15(4-5):461-470 PMID: 29447106
- 6. Shetty SP et al.. 2015. Selenocysteine incorporation: A trump card in the game of mRNA decay.. Biochimie 114:97-101 PMID: 25622574
- 7. Howard MT et al.. 2019. New Directions for Understanding the Codon Redefinition Required for Selenocysteine Incorporation.. Biol Trace Elem Res 192(1):18-25 PMID: 31342342
- 8. Varlamova EG et al.. 2013. [Biosyinthesis and mechanism of selenocysteine incorporation into synthesized proteins].. Mol Biol (Mosk) 47(4):558-67 PMID: 24466745
